Walleye Trading LLC Altimmune, Inc. Transaction History

Walleye Trading LLC

$52.6 Billion
Q2 2025

A detailed history of Walleye Trading LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Walleye Trading LLC holds 30,400 shares of ALT stock, worth $123,728. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,400

Holding current value

$123,728

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$6.02 - $9.85 $114,229 - $186,903	18,975 New	18,975 $136,000
Q1 2024 May 15, 2024	SELL	$8.22 - $13.81 $378,292 - $635,550	-46,021 Reduced 74.71%	15,579 $158,000
Q4 2023 Feb 14, 2024	BUY	$2.14 - $11.62 $89,024 - $483,391	41,600 Added 208.0%	61,600 $693,000
Q3 2023 Nov 14, 2023	SELL	$2.4 - $3.45 $38,952 - $55,993	-16,230 Reduced 44.8%	20,000 $52,000
Q2 2023 Aug 14, 2023	SELL	$3.45 - $5.97 $23,753 - $41,103	-6,885 Reduced 15.97%	36,230 $127,000
Q1 2023 May 15, 2023	SELL	$4.19 - $16.83 $147,525 - $592,567	-35,209 Reduced 44.95%	43,115 $181,000
Q4 2022 Feb 14, 2023	BUY	$8.74 - $16.45 $684,551 - $1.29 Million	78,324 New	78,324 $1.29 Million
Q2 2022 Aug 08, 2022	BUY	$3.94 - $11.77 $141,599 - $423,002	35,939 New	35,939 $420,000
Q1 2022 May 16, 2022	SELL	$5.9 - $9.45 $289,589 - $463,834	-49,083 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.69 - $12.48 $426,531 - $612,555	49,083 New	49,083 $450,000

Others Institutions Holding ALT

# of Institutions

213

Shares Held

36M

Call Options Held

4.92M

Put Options Held

4.18M

Black Rock Inc. New York, NY

5.32M
Shares

$21.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$21 Million
0.0% of portfolio
State Street Corp Boston, MA

2.75M
Shares

$11.2 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.75M
Shares

$11.2 Million
0.64% of portfolio
Geode Capital Management, LLC Boston, MA

1.93M
Shares

$7.87 Million
0.0% of portfolio

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $200M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account